Evidence map›Paper›PMID 34933332›Full record

ArticleBlood advances2022

Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report.

Nora Balas, Lindsey Hageman, Jessica Wu, Liton Francisco, Elizabeth Schlichting, Alysia Bosworth, Hok Sreng Te, F Lennie Wong, Wendy Landier, Donna Salzman and 5 more

Abstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nora BalasInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Lindsey HagemanInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Jessica WuInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Liton FranciscoInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Elizabeth SchlichtingInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Alysia BosworthDepartment of Population Sciences and Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA; and.ORCID 0000-0002-0662-5699
Hok Sreng TeDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
F Lennie WongDepartment of Population Sciences and Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA; and.
Wendy LandierInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-3319-5652
Donna SalzmanInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Daniel J WeisdorfDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.ORCID 0000-0001-8078-8579
Stephen J FormanDepartment of Population Sciences and Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA; and.
Mukta AroraDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.ORCID 0000-0001-9362-0556
Saro H ArmenianDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.ORCID 0000-0003-2604-8603
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.

Funding

BMT Survivor Study-2 (BMTSS-2)U01CA213140 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BHATIA, SMITA · 2019 to 2023
$6.8M
BONE MARROW TRANSPLANT (BMT) SURVIVORS STUDYR01CA078938 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI BHATIA, SMITA · 2000 to 2003
$1.6M
NCI NIH HHS R01 CA078938NCI NIH HHS U01 CA213140
6 · The paper itself

Abstract

We examine the impact of conditioning intensity (low intensity: nonmyeloablative/reduced intensity vs high intensity: myeloablative) and total body irradiation (TBI) on the probability of live birth after blood or marrow transplantation (BMT). Study participants were drawn from the BMT Survivor Study (BMTSS) and included 1607 transplant survivors between 1974 and 2014 at age ≤45 years, with survival ≥2 years post-BMT and age at study ≥18 years. Closest-age, same-sex biologic siblings (n = 172) were 1:1 matched with 172 survivors. Survivors and siblings self-reported information on sociodemographic, chronic health conditions, and pregnancies. Within survivor analysis: the association between the primary exposure variable (no TBI/low-intensity conditioning; 200 to 800 cGy TBI/low-intensity conditioning; no TBI/high-intensity conditioning; >800 cGy TBI/high-intensity conditioning) and the odds of no post-BMT live birth were examined using multivariable logistic regression, adjusting for clinical and demographic variables. Median age at BMT was 31 years (IQR, 0 to 45), and median length of follow-up was 14.3 years (IQR, 2.4 to 41.4); 39.3% were autologous BMT recipients, and 46.6% were female. Overall, 120 (8.7%) survivors reported post-BMT live births. Receipt of >800 cGy TBI/high-intensity conditioning (odds ratio [OR], 3.7; 95% CI, 1.9-7.0; ref: no TBI/low-intensity conditioning) was associated with higher odds of reporting no live birth post-BMT. In contrast, 200 to 800 cGy TBI/low-intensity conditioning (OR, 1.3; 95% CI, 0.5-3.3), and no TBI/high-intensity conditioning (OR, 0.9; 95% CI, 0.5-1.7) were at similar risk of reporting post-BMT live birth as no TBI/low-intensity conditioning. Comparison with biologic siblings: Using conditional logistic regression, we found that BMT survivors were more likely to report no live birth (OR, 2.0; 95% CI, 1.2-3.3) compared with siblings. These findings could inform conditioning intensity options for patients wishing to preserve fertility post-BMT.

Indexed as

Bone Marrow TransplantationLive BirthBone MarrowFemaleHumansMaleMiddle AgedPregnancyProbabilityTransplantation Conditioning

Identifiers

PMID34933332
PMCPMC9043940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.